Page last updated: 2024-11-11

Cudraflavone A

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5316261
CHEMBL ID230558
CHEBI ID176046

Synonyms (11)

Synonym
CHEBI:176046
7,15-dihydroxy-19,19-dimethyl-11-(2-methylprop-1-enyl)-2,10,20-trioxapentacyclo[12.8.0.03,12.04,9.016,21]docosa-1(22),3(12),4(9),5,7,14,16(21),17-octaen-13-one
cudraflavone a
3,8-dihydroxy-11,11-dimethyl-6-(2-methyl-propenyl)-6h,11h-5,12,14-trioxa-benzo[a]naphthacen-7-one
CHEMBL230558 ,
(-)-cudraflavone a
bdbm50217274
isocyclomorusin
LMPK12110923
96843-73-1
DTXSID101319079
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
extended flavonoidAny flavonoid with one or more rings fused on to the phenyl substituted benzopyran framework.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (15)

Assay IDTitleYearJournalArticle
AID448783Noncompetitive inhibition of Clostridium welchii neuraminidase by Dixon plot2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Structural characteristics of flavanones and flavones from Cudrania tricuspidata for neuraminidase inhibition.
AID1781724Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition incubated for 16 to 18 hrs by broth microdilution method
AID448782Inhibition of Clostridium welchii neuraminidase2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Structural characteristics of flavanones and flavones from Cudrania tricuspidata for neuraminidase inhibition.
AID1781719Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as bacterial growth inhibition incubated for 16 to 18 hrs by broth microdilution method
AID292582Inhibition at monoamine oxidase in mouse brain2007Journal of natural products, Jul, Volume: 70, Issue:7
Prenylated xanthones from the root bark of Cudrania tricuspidata.
AID1327079Neuroprotective activity in human SH-SY5Y cells assessed as reduction in oxygen glucose deprivation-induced cell death incubated for 16 hrs under hypoxic condition followed by incubation for 24 hrs under normoxic condition by MTT assay2016Journal of natural products, 08-26, Volume: 79, Issue:8
Chemical Constituents Isolated from the Root Bark of Cudrania tricuspidata and Their Potential Neuroprotective Effects.
AID1327077Neuroprotective activity in human SH-SY5Y cells assessed as reduction in 6-OHDA-induced cell death measured after 24 hrs by MTT assay2016Journal of natural products, 08-26, Volume: 79, Issue:8
Chemical Constituents Isolated from the Root Bark of Cudrania tricuspidata and Their Potential Neuroprotective Effects.
AID1781721Antibacterial activity against Acinetobacter baumannii BAA 1605 assessed as bacterial growth inhibition incubated for 16 to 18 hrs by broth microdilution method
AID376640Selectivity index, ratio of CC50 for mouse RAW264.7 cells to IC50 for nitric oxide production in mouse RAW264.7 cells2006Journal of natural products, Apr, Volume: 69, Issue:4
Prenylated flavonoids from the heartwood of Artocarpus communis with inhibitory activity on lipopolysaccharide-induced nitric oxide production.
AID1327078Neuroprotective activity in human SH-SY5Y cells assessed as reduction in 1-methyl-4-phenylpyridinium ion-induced cell death after 48 hrs by MTT assay2016Journal of natural products, 08-26, Volume: 79, Issue:8
Chemical Constituents Isolated from the Root Bark of Cudrania tricuspidata and Their Potential Neuroprotective Effects.
AID1781720Antibacterial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition incubated for 16 to 18 hrs by broth microdilution method
AID1781722Antibacterial activity against Klebsiella pneumoniae BAA-1705 assessed as bacterial growth inhibition incubated for 16 to 18 hrs by broth microdilution method
AID1781723Antibacterial activity against Enterococcus NR 31884 assessed as bacterial growth inhibition incubated for 16 to 18 hrs by broth microdilution method
AID376638Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells assessed as nitrite accumulation after 20 hrs2006Journal of natural products, Apr, Volume: 69, Issue:4
Prenylated flavonoids from the heartwood of Artocarpus communis with inhibitory activity on lipopolysaccharide-induced nitric oxide production.
AID376639Cytotoxicity against mouse RAW264.7 cells by MTT assay2006Journal of natural products, Apr, Volume: 69, Issue:4
Prenylated flavonoids from the heartwood of Artocarpus communis with inhibitory activity on lipopolysaccharide-induced nitric oxide production.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.53 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]